lactulose(redirected from Enulose)
Also found in: Dictionary.
Apo-Lactulose (CA), Constulose, Duphalac (UK), Enulose, Euro-Lac (CA), Generlac, Gen-Lac (CA), GPI-Lactulose (CA), Kristalose, Lactugal (UK), Lactulax (CA), Lemlax (UK), PMS-Lactulose (CA), Ratio-Lactulose (CA), Regulose (UK)
Pharmacologic class: Osmotic
Therapeutic class: Laxative
Pregnancy risk category B
Produces osmotic effect, which increases water content in colon and enhances peristalsis. Breakdown products in colon lead to acidification of colonic contents, softening of feces, and decreased ammonia absorption from colon to systemic circulation. These effects reduce blood ammonia level in portal-system encephalopathy.
Powder (single-use packets): 10 g, 20 g
Syrup: 10 g/15 ml
⊘Indications and dosages
Adults: 10 to 20 g (15 to 30 ml) P.O. daily; may increase to 60 ml daily p.r.n.
➣ Portal-system encephalopathy
Adults: 20 to 30 g (30 to 45 ml) P.O. three or four times daily until two or three soft stools are produced daily. Therapy may continue over long term. Or, 300 ml P.O. with 700 ml of water or normal saline solution. Or, as retention enema by rectal balloon catheter, repeated q 4 to 6 hours.
• Patients requiring low-galactose diet
Use cautiously in:
• diabetes mellitus
• elderly patients
• pregnant or breastfeeding patients
• Don't give concurrently with other laxatives.
• Dissolve contents of single-use packet in 4 oz of water or juice.
• Dilute syrup with water or fruit juice to mask taste.
GI: nausea, vomiting, diarrhea, intestinal cramps, abdominal distention, flatulence
Metabolic: hyperglycemia (in diabetic patients), hypokalemia, hypernatremia
Drug-drug.Anti-infectives: decreased lactulose efficacy
Other laxatives: interference with response to lactulose (in patients with hepatic encephalopathy)
Drug-diagnostic tests.Blood ammonia: 25% to 50% decrease
Glucose: increased level (in diabetic patients)
Potassium: decreased level
Sodium: increased level
• Watch for adverse GI reactions.
• Check stool consistency and frequency.
• Monitor electrolyte levels, especially in elderly patients.
• Check blood glucose level in diabetic patients.
• Instruct patient to dissolve contents of single-use packet in 4 oz of water or juice.
• Suggest that patient dilute syrup with water or juice to mask taste.
• Tell patient drug may cause flatulence and intestinal cramps at first, but these symptoms usually subside.
• Inform patient that excessive use may cause diarrhea and excessive fluid loss.
• Encourage patient to drink adequate fluids and to report signs and symptoms of dehydration.
• As appropriate, review all other significant adverse reactions and interactions, especially those related to the drugs and tests mentioned above.